If anything, patient groups are advocating for access in-spite of minimal funding

If anything, it is remarkable that patient groups advocate so strongly for access to medicines when the companies that make them provide so little of their funding. Advocacy that persists without the money cannot be explained by the money. It is explained by what patients need. …